Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

AI's role in the Fujifilm/Hitachi acquisition

FUJIFILM Corporation announced Wednesday, Dec. 18, that it has entered into an agreement to purchase Hitachi’s diagnostic imaging business for more than $1.6 billion. AI appears to have played an important role in Fujifilm’s decision.

Thumbnail

Fujifilm moves forward with $1.6B purchase of Tokyo-based rival Hitachi's imaging line

The camera and photocopier giant’s move would make it one of the largest imaging companies in the world, with scale to rival the big four.
 

Thumbnail

Targeting out-of-network radiologists, other specialties could cut healthcare spending by $40B

Yale University researchers recently made their pitch to address the practice of surprise medical billing in a new study, published Monday, Dec. 16, in Health Affairs

Thumbnail

Fujifilm eyes purchase of Hitachi’s imaging business for $1.5B

The Tokyo-based company hopes to add scale to better compete with the top global players in imaging. 

Thumbnail

Congress moves to permanently repeal medical device tax

Legislators are expected to pass the bill this week, which will then be sent on to President Trump to sign into law before government funding expires at midnight Friday.

Thumbnail

Intel acquires AI startup for $2B

Intel Corporation has acquired Habana Labs, a Tel-Aviv, Israel-based AI startup founded in 2016, for approximately $2 billion.

Thumbnail

FDA approves icosapent ethyl to reduce CV risk

The FDA has approved Amarin’s Vascepa—icosapent ethyl—to reduce cardiovascular risk beyond cholesterol-lowering therapy in high-risk patients, making it the first drug of its kind to be approved in the U.S.

Thumbnail

AI-powered polyp detector gains CE certification

PENTAX Medical, a division of the HOYA Group focused on endoscopic solutions, has received CE mark approval for its AI-powered polyp detector.